Ftse Mib
34.271,63
0,84%
DAX
18.246,54
0,41%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.682,53
0,82%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Revelation Biosciences Inc (REVB) Revelation Biosciences Inc (REVB) Notizie

Revelation Biosciences Inc

REVB
2,35
0,00 (0,00%)
07 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/3/202421:15BWRevelation Biosciences, Inc. Announces Financial Results for..
13/3/202414:00BWRevelation Biosciences Inc. Gives Oral Presentation at..
12/3/202414:00BWRevelation Biosciences Inc. to Participate in a Virtual..
04/3/202415:00BWRevelation Biosciences Inc. Announces Commencement of First..
14/2/202402:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:00BWRevelation Biosciences Inc. Receives Invitation to Give an..
12/2/202416:19EDGAR2Form SCHEDULE 13G/A - Statement of acquisition of beneficial..
08/2/202422:01EDGAR2Form 8-K - Current report
05/2/202422:41BWRevelation Biosciences Inc. Announces Closing of $6.2..
02/2/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202412:00BWRevelation Biosciences Inc. Announces Pricing of $6.2..
30/1/202423:21EDGAR2Form 8-K - Current report
30/1/202421:32EDGAR2Form S-1/A - General form for registration of securities..
30/1/202415:00BWRevelation Biosciences Inc. to Present at The International..
29/1/202423:32EDGAR2Form S-1/A - General form for registration of securities..
23/1/202422:18EDGAR2Form 8-K - Current report
23/1/202415:00BWRevelation Biosciences Inc. Announces 1-for-30 Reverse Stock..
22/1/202422:01EDGAR2Form 8-K - Current report
22/12/202323:06EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202319:23EDGAR2Form S-1 - General form for registration of securities under..
12/12/202322:59EDGAR2Form PRE 14A - Other preliminary proxy statements
13/11/202322:30EDGAR2Form 8-K - Current report
13/11/202322:05BWRevelation Biosciences, Inc. Announces Financial Results for..
09/11/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202322:26EDGAR2Form 8-K - Current report
12/10/202315:00BWGemini Induces Pharmacologic Activity and Related..
04/10/202315:00BWRevelation Biosciences, Inc. to Present at the 2023 ROTH..
02/10/202322:24EDGAR2Form 8-K - Current report
02/10/202315:00BWRevelation Biosciences Inc. Announces Appointment of Lakhmir..
11/8/202322:30EDGAR2Form 8-K - Current report
11/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202322:10BWRevelation Biosciences Inc. Announces Financial Results for..
11/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form 8-K - Current report
14/7/202322:51EDGAR2Form 8-K - Current report
07/7/202322:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/7/202322:07EDGAR2Form 8-K - Current report
29/6/202322:23EDGAR2Form 8-K - Current report
29/6/202315:00BWREMINDER: Revelation Biosciences, Inc. Urges All..
12/6/202322:15BWRevelation Biosciences Inc. Announces Adjournment of 2023..
22/5/202315:00BWRevelation Biosciences Inc. Announces Financial Results for..
Apertura: Min: Max:
Chiusura: 2,35

La tua Cronologia

NASDAQ
REVB
Revelation Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network